Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity

Published:2015-03-09 Issue:49 Volume:34 Page:5960-5970
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Cao K,Wang G,Li W,Zhang L,Wang R,Huang Y,Du L,Jiang J,Wu C,He X,Roberts A I,Li F,Rabson A B,Wang Y,Shi Y

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc201546.pdf

Reference50 articles.

1. Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.

2. Yu P, Fu YX . Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 2006; 86: 231–245.

3. Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y et al. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 2004; 5: 141–149.

4. Boni A, Muranski P, Cassard L, Wrzesinski C, Paulos CM, Palmer DC et al. Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers. Blood 2008; 112: 4746–4754.

5. Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012; 366: 2455–2465.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel post-translational modifications of protein by metabolites with immune responses and immune-related molecules in cancer immunotherapy;International Journal of Biological Macromolecules;2024-10

2. Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer;Journal of Medicinal Chemistry;2024-08-07

3. First-line treatment with KN046, chemotherapy and palliative radiotherapy for advanced esophageal squamous cell carcinoma: an open-label, dose escalation, and dose expansion phase Ib trial;Cancer Immunology, Immunotherapy;2024-08-06

4. Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study;JMIR Research Protocols;2024-04-04

5. The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer;International Journal of Molecular Sciences;2024-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3